Literature DB >> 16523295

Sympathetic ophthalmia after surgical resection of iridociliary melanoma. A case report.

Jose Garcia-Arumi1, Marc Montolio Gil, Merce Morral Palau, Antonio Segura Garcia.   

Abstract

BACKGROUND: We report a case of sympathetic ophthalmia with systemic findings following resection of a malignant melanoma of the iris and ciliary body, and describe the treatment and clinical outcome.
METHODS: A 49-year-old man underwent sector iridocyclectomy of a malignant iridociliary melanoma of the right eye. Five weeks later, he was diagnosed with sympathetic ophthalmia. Snellen's best-corrected visual acuity, fluorescein angiography, electroretinography, cerebrospinal fluid analysis and audiometry were performed. High-dose systemic steroid and immunosuppressive (cyclosporine and azathioprine) therapy was prescribed. Two months later chorioretinitis and macular edema persisted, and intravitreous triamcinolone was injected into the right eye.
RESULTS: Five weeks after resection of an iridociliary melanoma, our patient had reported acute bilateral vision loss. Visual acuity was hand motion in both eyes. Examination showed bilateral granulomatous uveitis, diffuse choroiditis with Dalen-Fuchs nodules, papillitis and vitritis. On fluorescein angiography multiple hyperfluorescent dots, which coalesced in areas of exudative retinal detachment, were evident. The patient presented meningismus with pleocytosis on cerebrospinal fluid analysis, and sensorineural deafness. Sympathetic ophthalmia was diagnosed. High-dose intravenous steroids followed by oral prednisone at a tapering dose and immunosuppressive agents (cyclosporine and azathioprine), topical steroids in both eyes and intravitreal steroids in the right eye were administered. Phacoemulsification and intraocular lens implantation were performed to treat a dense cataract of the right eye. After 24 months of follow-up, best-corrected visual acuity was 20/200 in the right eye and 20/25 in the left; no signs of intraocular inflammation were observed and neurological signs had resolved. Low maintenance doses of systemic steroids and immunosuppressive agents were administered up to month 18 of follow-up to avoid recurrence.
CONCLUSIONS: Sympathetic ophthalmia is a rare, but severe disease that can occur after resection of iridociliary melanoma. High-dose steroid therapy and supplementation with immunosuppressive agents early in the course of the disease was effective in resolving the condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523295     DOI: 10.1007/s00417-006-0299-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Sympathetic ophthalmia associated with high frequent deafness.

Authors:  M Comer; C Taylor; S Chen; K Martin; K Jordan; P Meyer
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

Review 2.  Postoperative sympathetic ophthalmia.

Authors:  A T Gasch; C S Foster; C L Grosskreutz; L R Pasquale
Journal:  Int Ophthalmol Clin       Date:  2000

3.  Sympathetic ophthalmia risk following vitrectomy: should we counsel patients?

Authors:  D J Kilmartin; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

Review 4.  Enucleation, evisceration, and sympathetic ophthalmia.

Authors:  J R Bilyk
Journal:  Curr Opin Ophthalmol       Date:  2000-10       Impact factor: 3.761

5.  32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992.

Authors:  C C Chan; R G Roberge; S M Whitcup; R B Nussenblatt
Journal:  Arch Ophthalmol       Date:  1995-05

6.  Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients.

Authors:  D J Kilmartin; D Wilson; J Liversidge; A D Dick; J Bruce; R W Acheson; S J Urbaniak; J V Forrester
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

7.  T cell immune responses against melanoma and melanocytes in cancer and autoimmunity.

Authors:  Y Kawakami; Y Suzuki; T Shofuda; Y Kiniwa; T Inozume; K Dan; T Sakurai; T Fujita
Journal:  Pigment Cell Res       Date:  2000

8.  Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment.

Authors:  R M Conway; W C Chua; C Qureshi; F A Billson
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

9.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

10.  Changing trends in sympathetic ophthalmia.

Authors:  Brendan J Vote; Anthony Hall; James Cairns; Robert Buttery
Journal:  Clin Exp Ophthalmol       Date:  2004-10       Impact factor: 4.207

View more
  2 in total

Review 1.  Sympathetic ophthalmia.

Authors:  Claudia Patricia Castiblanco; Ron A Adelman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-16       Impact factor: 3.117

Review 2.  Intraocular biopsy in uveitis.

Authors:  Gazal Patnaik; Radha Annamalai; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.